Active Implantable Medical Devices Market Share Analysis of The Top Industry Players

Active Implantable Medical Devices market is projected to reach $28,878.6 million by 2023, growing at a CAGR of 8.0% during 2017 - 2023.
 
 
Spread the Word
Listed Under

Tag:
* Active Implantable

Industry:
* Medical

Location:
* Bella Vista - Arkansas - US

Subject:
* Reports

BELLA VISTA, Ark. - Oct. 22, 2019 - PRLog -- According to the study, the global active implantable medical devices market is likely to grow from $17.0 billion in 2016 to $28.9 billion by 2023. Technological advancements, increasing prevalence of cardiovascular diseases, rising healthcare expenditures and increasing research and development activities have been driving the growth of the global active implantable medical devices market (https://www.psmarketresearch.com/market-analysis/active-implantable-medical-devices-market). The market is further expected to gain revenue due to increasing geriatric population and incidence of neurological disorders. Development of subcutaneous implantable cardioverter defibrillators along with the increasing demand from developing nations is expected to create ample growth opportunities in the global active implantable medical devices market.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/active-implantable-medical-devices-market/report-sample
Geographically, North America has been the largest market for active implantable medical devices, with the U.S. being the larger contributor to the regional market as compared to Canada. The key factor driving the North American active implantable medical devices market are technological advancements, high healthcare expenditure, growing geriatric population, improved healthcare infrastructure and growing prevalence of cardiovascular diseases. The emerging economies in Asia-Pacific, especially China and India, are expected to grow tremendously in future, which is expected to bring the Asia-Pacific market approximately equal to the European market by 2023. Asia-Pacific presents several growth opportunities for the active implantable medical devices manufacturers due to the rapid expansion of healthcare industry in the region.

Key companies in the active implantable medical devices (https://www.psmarketresearch.com/market-analysis/active-i...) market are acquiring other companies to strengthen their position in the global market. In January 2017, Abbott completed the acquisition of St. Jude Medical, Inc., including its atrial fibrillation, structural heart and heart failure business as well as neuromodulation business. Similarly, in January 2015, Medtronic plc completed the acquisition of Covidien plc. Under the terms of the acquisition agreement, Medtronic, Inc. and Covidien plc are now combined under Medtronic plc. The acquisition strengthened position of the company in the global market with a large number of product offerings.

Some of the other key players in the market include Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC, William Demant Holding A/S, Nurotron Biotechnology Co. Ltd., Sonova Holding AG, and MED-EL.
(https://www.psmarketresearch.com/market-analysis/active-implantable-medical-devices-market)

Contact
Pramod Kumar
***@gmail.com
End
Email:***@gmail.com
Tags:Active Implantable
Industry:Medical
Location:Bella Vista - Arkansas - United States
Subject:Reports
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
P&S Intelligence News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share